Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes
Exercise Training, CACs, and Vascular Function in Older Veterans With IGT (Impaired Glucose Tolerance)
Sponsor: Baltimore VA Medical Center
Listed as NCT01176578, this NA trial focuses on Type 2 Diabetes Mellitus and remains ongoing. Sponsored by Baltimore VA Medical Center, it has been updated 12 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Oct 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
May 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Apr 2022 — May 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Feb 2021 — Apr 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baltimore VA Medical Center
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .